The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sherman Jeffrey W since 2015.
This trader's CIK number is 1230482.
At the time of last reporting, Sherman Jeffrey W was the Director of Xeris Biopharma Holdings, Inc.. (stock ticker symbol XERS).
Also see all insider trading activities at Xeris Biopharma Holdings, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | XERS | 0 | $0 | 42,232 | $334,519 | 47,040 | $313,286 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | HZNP | 0 | $0 | 6,736 | $761,672 | 0 | $0 |
| 2022 | HZNP | 0 | $0 | 70,361 | $7,781,560 | 66,455 | $188,876 |
| 2021 | HZNP | 0 | $0 | 106,347 | $10,797,090 | 103,968 | $433,769 |
| 2020 | HZNP | 0 | $0 | 146,421 | $9,423,474 | 51,766 | $333,398 |
| 2018 | HZNP | 0 | $0 | 0 | $0 | 34,750 | $0 |
| 2017 | HZNP | 0 | $0 | 0 | $0 | 46,000 | $0 |
| 2016 | HZNP | 0 | $0 | 7,000 | $140,000 | 54,500 | $20,400 |
| 2015 | HZNP | 0 | $0 | 39,093 | $1,291,247 | 100,495 | $210,970 |
1. Xeris Biopharma Holdings, Inc. (XERS)
2. Horizon Therapeutics Public Ltd Co (HZNP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-28 | XERS | Option Ex | 47,040 | 6.66 | 313,286 |
| 2025-08-28 | XERS | Sale | 42,232 | 7.92 | 334,519 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-11 | HZNP | Sale | 3,368 | 113.10 | 380,920 |
| 2023-01-10 | HZNP | Sale | 3,368 | 113.05 | 380,752 |
| 2022-12-12 | HZNP | Sale | 28,352 | 111.44 | 3,159,688 |
| 2022-04-06 | HZNP | Sale | 42,009 | 110.02 | 4,621,872 |
| 2022-03-18 | HZNP | Option Ex | 8,531 | 22.14 | 188,876 |
| 2022-01-21 | HZNP | Option Ex | 5,354 | .00 | 0 |
| 2022-01-05 | HZNP | Option Ex | 52,570 | .00 | 0 |
| 2021-10-27 | HZNP | Option Ex | 10,729 | 7.61 | 81,647 |
| 2021-09-21 | HZNP | Option Ex | 46,271 | 7.61 | 352,122 |
| 2021-09-21 | HZNP | Sale | 46,271 | 110.00 | 5,089,810 |
| 2021-07-01 | HZNP | Sale | 60,076 | 95.00 | 5,707,280 |
| 2021-01-21 | HZNP | Option Ex | 5,353 | .00 | 0 |
| 2021-01-05 | HZNP | Option Ex | 41,615 | .00 | 0 |
| 2020-12-07 | HZNP | Sale | 63,078 | 71.36 | 4,501,056 |
| 2020-12-08 | HZNP | Sale | 40,764 | 70.96 | 2,892,613 |
| 2020-10-21 | HZNP | Option Ex | 13,000 | 7.61 | 98,930 |
| 2020-07-06 | HZNP | Sale | 9,100 | 57.50 | 523,250 |
| 2020-05-11 | HZNP | Option Ex | 33,479 | 4.96 | 166,055 |
| 2020-05-11 | HZNP | Sale | 33,479 | 45.00 | 1,506,555 |
| 2020-03-11 | HZNP | Option Ex | 5,287 | 12.94 | 68,413 |
| 2018-03-23 | HZNP | Option Ex | 19,250 | .00 | 0 |
| 2018-01-02 | HZNP | Option Ex | 15,500 | .00 | 0 |
| 2017-03-23 | HZNP | Option Ex | 19,250 | .00 | 0 |
| 2017-01-02 | HZNP | Option Ex | 26,750 | .00 | 0 |
| 2016-12-16 | HZNP | Option Ex | 8,500 | 2.40 | 20,400 |
| 2016-08-02 | HZNP | Sale | 2,900 | 20.00 | 58,000 |
| 2016-03-23 | HZNP | Option Ex | 19,250 | .00 | 0 |
| 2016-02-26 | HZNP | Sale | 4,100 | 20.00 | 82,000 |
| 2016-01-02 | HZNP | Option Ex | 26,750 | .00 | 0 |
| 2015-12-15 | HZNP | Option Ex | 30,442 | 3.68 | 112,026 |
| 2015-12-10 | HZNP | Sale | 4,456 | 20.00 | 89,120 |
| 2015-12-08 | HZNP | Option Ex | 8,208 | .00 | 0 |
| 2015-09-21 | HZNP | Sale | 7,750 | 31.78 | 246,295 |
| 2015-07-15 | HZNP | Option Ex | 26,887 | 3.68 | 98,944 |
| 2015-07-15 | HZNP | Sale | 26,887 | 35.55 | 955,832 |
| 2014-12-08 | HZNP | Option Ex | 8,208 | .00 | 0 |
| 2015-01-02 | HZNP | Option Ex | 26,750 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sherman Jeffrey W (Director of Xeris Biopharma Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.